SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001802768-23-000029
Filing Date
2023-11-08
Accepted
2023-11-08 09:04:52
Documents
74
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rprx-20230930.htm   iXBRL 10-Q 2555174
2 EX-31.1 rprx-20230930ex311.htm EX-31.1 9257
3 EX-31.2 rprx-20230930ex312.htm EX-31.2 9293
4 EX-32 rprx-20230930ex32.htm EX-32 5018
  Complete submission text file 0001802768-23-000029.txt   10598911

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rprx-20230930.xsd EX-101.SCH 66924
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rprx-20230930_cal.xml EX-101.CAL 95026
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rprx-20230930_def.xml EX-101.DEF 369887
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rprx-20230930_lab.xml EX-101.LAB 787382
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rprx-20230930_pre.xml EX-101.PRE 518618
68 EXTRACTED XBRL INSTANCE DOCUMENT rprx-20230930_htm.xml XML 1771943
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Filer) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39329 | Film No.: 231386250
SIC: 2834 Pharmaceutical Preparations